CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

CELZ$0.62+2.6%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Unaudited Condensed Consolidated Balance Sheets

	September 30, 2025	December 31, 2024
ASSETS
CURRENT ASSETS
Cash	$5,375,511	$5,940,402
Inventory	994	2,194
Prepaids and other current assets	35,036	192,707
Total Current Assets	5,411,541	6,135,303
OTHER ASSETS
Other assets	3,281	3,281
Licenses, net of amortization	438,181	530,559
TOTAL ASSETS	$5,853,003	$6,669,143
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$247,159	$273,530
Accrued expenses	-	39,920
Advances from related party	14,194	14,194
Total Current Liabilities	261,353	327,644
TOTAL LIABILITIES	261,353	327,644
Commitments and contingencies
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 10,000,000 shares authorized at September 30, 2025 and December 31, 2024	-	-
Common stock, $0.001 par value, 25,000,000 shares authorized; 2,585,532 and 1,748,428 issued and 2,580,532 and 1,748,428 outstanding at September 30, 2025 and December 31, 2024, respectively	2,586	1,749
Additional paid-in capital	74,298,311	70,931,663
Accumulated deficit	(68,699,247)	(64,591,913)
Treasury stock, at cost, 5,000 and 0 shares as of September 30, 2025 and December 31, 2024, respectively	(10,000)	-
TOTAL STOCKHOLDERS' EQUITY	5,591,650	6,341,499
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$5,853,003	$6,669,143

The accompanying notes are an integral part of these condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.